Comprehensive diabetes center
A digital app for clinicians developed by UAB researchers classifies diabetes into five subtypes, enabling more personalized treatment and better outcomes for patients.
UAB scientists discovered an oral drug stopped weight rebound after discontinuation or cessation of GLP‑1 treatment in preclinical studies, opening the door to a new approach for maintaining weight loss.
Research published in the journal Gut suggests that nutraceutical strategies restoring tryptophan metabolism and IPA levels may serve as both biomarkers and therapeutic approaches for diabetic retinopathy.
Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.
The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.
A UAB expert explains what a certified diabetes and education specialist is and how they can benefit patients with diabetes.
A cluster analysis in the Deep South showed that racial background significantly influences diabetes subtype distribution.
A healthy lifestyle is about small changes over time that build upon each other.
Lund is the fifth Distinguished Fellow from UAB named since 2019, a sign of the strength of immunology research at UAB.
These results add an additional, mechanistic aspect to further explain how the decades-old blood pressure medication verapamil can preserve beta cell function in Type 1 diabetes patients by affecting the hormone insulin-like growth factor 1.
This study will enroll patients to evaluate which combination of three proposed interventions — including health coaching, food delivery and remote patient monitoring — will help patients manage diabetes and also be sustainable for health systems to implement.
Given the rising rates of obesity and diabetes, semaglutide could be used effectively to reduce the burden of these chronic diseases.
Knockout of TXNIP improves diabetes-associated hyperglycemia and hyperglucagonemia.
The Council on Basic Cardiovascular Sciences, known as the BCVS, is one of the largest councils at the American Heart Association, and it is one of the largest organizations in cardiovascular sciences globally, with more than 4,700 members.
This therapy, using sustained release of nitric oxide, may be a novel, efficient and safe way to prevent and treat multiple metabolic diseases.
Benefits of the blood pressure medication verapamil include delayed disease progression, lowered insulin requirements and preservation of some beta cell function.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — was associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes.
The drug candidate is a non-toxic small molecule that given orally effectively rescued mice from models of Type 1 and Type 2 diabetes.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.